Company intelligence
Medlive
Education that empowers
About Medlive
New medical therapies are emerging at an unprecedented rate. It can be difficult to keep pace with the latest healthcare discoveries and changes. At Medlive, you can gain access to timely, credible medical education led by renowned specialists and leading centers of excellence. Millions of healthcare providers, patients, and caregivers engage with our online content to discover insights on how to manage different cancers, neurological disorders, rare diseases and other conditions. Our education will empower you to make informed medical decisions based on the latest science. At Medlive, we are dedicated to improving health outcomes for all.
Verified activity
Signals from Medlive
5 published signals
Presence & Recognition
Medlive published an article discussing how androgen deprivation therapy (ADT) strategies may impact cardiovascular outcomes in patients with prostate cancer through expert-led case-based discussions.
Reported by Medlive
Presence & Recognition
Medlive is heading to Orlando for the AANEM 2026 conference.
Reported by Medlive
Presence & Recognition
Medlive has two posters accepted for the AANEM 2026 Clinical Trial engagement and rare neurological disease sessions developed in collaboration with the National Organization for Rare Disorders and the Myasthenia Gravis Foundation of America, Inc.
Reported by Medlive
Presence & Recognition
Medlive presented outcomes research at the 2026 FOP Drug Development Forum alongside the International FOP Association, the National Organization for Rare Disorders, and the Rare Bone Disease Alliance.
Reported by Medlive
Products & Services
Medlive launched a new homepage featuring an updated education platform designed to help clinicians find science-related education content more efficiently.
Reported by Medlive